Prostaglandin analogue
Bimatoprost
Brand names: Lumigan
Adult dose
Dose: 1 drop OD evening
Route: Ophthalmic
Frequency: OD
Clinical pearls
- NICE NG81 glaucoma / OHT — first-line topical PG analogue
- RCOphth
- Counsel re iris/skin pigmentation, eyelash growth (irreversible)
Contraindications
- Hypersensitivity
- Active intraocular inflammation
Side effects
- Conjunctival hyperaemia
- Eyelash growth (hypertrichosis)
- Iris pigmentation darkening (irreversible)
- Periorbital pigmentation
- Macular oedema (aphakic / pseudophakic)
- Headache
Interactions
- Other PG analogues (additive)
Monitoring
- IOP
- Visual fields
- Iris/skin colour
- Eyelash growth
Reference: BNF; NICE NG81; RCOphth; https://bnf.nice.org.uk/drugs/bimatoprost/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Acute Red Eye / Vision Loss Screen · RCOphth 2020; NICE CKS
- Idiopathic Intracranial Hypertension · ABN; consensus 2018
- Acute Red Eye Assessment · RCOphth / AAO
- Acute Angle Closure Glaucoma · RCOphth / EGS Guidelines
- Retinal Detachment · RCOphth Guidelines / EURETINA
- Diabetic Retinopathy — Screening and Management · NICE NG28 2016 / NHS DES Programme